Baseline Predictors for One-Year Visual Outcomes With Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration
Ophthalmology - Netherlands
doi 10.1016/j.ophtha.2012.07.042
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2013
Authors
Publisher
Elsevier BV